PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Daily ingestion of GP extract (30 mg/d for 4 weeks) decreased visceral fat area in non-obese female volunteers [PMID:24759256]. A standardized extract (250 mg twice daily for 12 weeks) significantly increased energy expenditure and reduced visceral fat in overweight adults [PMID:36329722].
Prolonged treatment (40 mg/d for 5 weeks) may recruit adaptive thermogenesis and reduce body fat in humans with low BAT activity [PMID:33952741].
Ethanolic extract reduced inflammation by 49% at 1000 mg/kg in a rat paw edema model [PMID:25293633].
Dietary inclusion of seeds (2-4%) modulated lipid profiles and attenuated hepatotoxicity in hypercholesterolemic rats [PMID:27339176].
Aqueous extracts stimulated male sexual behavior, increasing penile erection index and frequencies of intromission and ejaculation in rats [PMID:12122315].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 25293633 (2014) — Anti-inflammatory activity of grains of paradise (Aframomum melegueta Schum) extract. · Journal of agricultural and food chemistry
- 2.PMID: 20234758 (2009) — Effect of alligator pepper (Zingiberaceae aframomum melegueta) on first trimester pregnancy in Sprague Dawley rats. · Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria
- 3.PMID: 33952741 (2021) — Prolonged Treatment with Grains of Paradise (Aframomum melegueta) Extract Recruits Adaptive Thermogenesis and Reduces Body Fat in Humans with Low Brown Fat Activity. · Journal of nutritional science and vitaminology
- 4.PMID: 27339176 (2016) — Alligator pepper/Grain of Paradise (Aframomum melegueta) modulates Angiotensin-I converting enzyme activity, lipid profile and oxidative imbalances in a rat model of hypercholesterolemia. · Pathophysiology : the official journal of the International Society for Pathophysiology
- 5.